Syndax Pharmaceuticals Inc Quarterly Interest Expense in USD from Q1 2020 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: Syndax Pharmaceuticals Inc quarterly/annual Interest Expense history and growth rate from Q1 2020 to Q2 2024.
Syndax Pharmaceuticals Inc Interest Expense for the quarter ending June 30, 2024 was $45K, a 28.6% increase year-over-year.
Syndax Pharmaceuticals Inc Interest Expense for the twelve months ending June 30, 2024 was $233K, a 87.5% decline year-over-year.
Syndax Pharmaceuticals Inc annual Interest Expense for 2023 was $208K, a 93.4% decline from 2022.
Syndax Pharmaceuticals Inc annual Interest Expense for 2022 was $3.14M, a 65.2% increase from 2021.
Syndax Pharmaceuticals Inc annual Interest Expense for 2021 was $1.9M, a 19.4% decline from 2020.

Interest Expense, Trailing 12 Months (USD)

Interest Expense, Quarterly (USD)

Interest Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$233K	$45K	+$10K	+28.6%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-01
Q1 2024	$223K	$55K	+$15K	+37.5%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$208K	$63K	+$20K	+46.5%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-27
Q3 2023	$188K	$70K	-$1.68M	-96%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-02
Q2 2023	$1.87M	$35K	-$660K	-95%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-01
Q1 2023	$2.53M	$40K	-$611K	-93.9%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-08
Q4 2022	$3.14M	$43K	+$50K		Oct 1, 2022	Dec 31, 2022	10-K	2024-02-27
Q3 2022	$3.09M	$1.75M	+$1.1M	+169%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-02
Q2 2022	$1.99M	$695K	+$61K	+9.62%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-03
Q1 2022	$1.93M	$651K	+$28K	+4.49%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-08
Q4 2021	$1.9M	-$7K	-$642K	-101%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-27
Q3 2021	$2.54M	$649K	+$14K	+2.21%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	$2.53M	$634K	-$4K	-0.63%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-08
Q1 2021	$2.53M	$623K	+$174K	+38.8%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-09
Q4 2020	$2.36M	$635K			Oct 1, 2020	Dec 31, 2020	10-K	2023-02-28
Q3 2020		$635K			Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-15
Q2 2020		$638K			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-09
Q1 2020		$449K			Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.